Table of Contents

• Introduction to Synemol
• Chemical Composition and Properties
• Mechanism of Action
• Medical Uses of Synemol
• Formulations and Dosage
• Side Effects of Synemol
• Comparison to Other Topical Corticosteroids
• Synemol Alternatives and Comparisons
• Cost and Accessibility
• Regulatory and Safety Information
• Pharmacokinetics and Pharmacodynamics
• Patient Information
• Professional Healthcare Information
• Research and Clinical Studies
• Historical and Market Information
• References and Further Reading

Introduction to Synemol

Synemol is a topical corticosteroid medication used for the treatment of various skin conditions such as dermatitis, eczema, psoriasis, and seborrheic dermatitis. Its active ingredient is fluocinolone acetonide, a synthetic corticosteroid that has anti-inflammatory and anti-pruritic properties. Synemol is available in various formulations, including creams, gels, and ointments, and is commonly prescribed by dermatologists and healthcare practitioners for the management of chronic skin conditions.

Chemical Composition and Properties

The chemical name of fluocinolone acetonide, the active ingredient in Synemol, is 6α,9α-difluoro-11β,16α,17α,21-tetrahydroxypregna-1,4-diene-3,20-dione 16,17-acetonide. It has a molecular formula of C ₂₄H ₃₀F ₂O ₆ and a molecular weight of 452.49 g/mol. Fluocinolone acetonide is a white to off-white crystalline powder with a melting point of 267-269°C. It is practically insoluble in water but soluble in acetone and chloroform.

Synemol is also known by various synonyms, including Coriphate, Dermalar, Fluonid, Fluvean, Jellin, Synalar, and Synsac.

Mechanism of Action

Fluocinolone acetonide, the active ingredient in Synemol, is a synthetic corticosteroid that binds to the glucocorticoid receptor in the cytoplasm of target cells. This binding activates the receptor complex, which then translocates to the nucleus and binds to specific DNA sequences, resulting in the regulation of gene transcription. The anti-inflammatory effects of fluocinolone acetonide are mediated through the inhibition of inflammatory mediators such as prostaglandins and leukotrienes, as well as the suppression of the immune response.

Synemol also exhibits anti-pruritic and vasoconstrictive effects, which contribute to its efficacy in the treatment of various skin conditions characterized by inflammation, itching, and redness.

Medical Uses of Synemol

Synemol is primarily used for the treatment of various skin conditions, including:

• Dermatitis: Synemol is effective in managing different types of dermatitis, such as atopic dermatitis and contact dermatitis, by reducing inflammation, itching, and redness.
• Eczema: Synemol helps alleviate the symptoms of eczema, a chronic skin condition characterized by dry, itchy, and inflamed skin.
• Psoriasis: Synemol is used as a topical treatment for mild to moderate psoriasis, a skin disorder that causes the rapid buildup of skin cells, resulting in scaly, itchy patches.
• Seborrheic dermatitis: Synemol is effective in treating seborrheic dermatitis, a common skin condition that causes scaly patches and red skin, mainly on the scalp.
• Lichen simplex chronicus: Synemol is used to manage lichen simplex chronicus, a skin condition characterized by thick, leathery skin as a result of chronic scratching or rubbing.

In addition to its dermatological uses, Synemol is also used in the treatment of other conditions, such as:

• Diabetic macular edema: Intravitreal implants containing fluocinolone acetonide, such as Iluvien, are used to treat diabetic macular edema, a complication of diabetes that causes swelling in the macula, leading to vision loss.
• Non-infectious uveitis: Fluocinolone acetonide intravitreal implants are also used in the management of non-infectious uveitis, an inflammation of the uvea, the middle layer of the eye.
• Eczematous otitis externa: Synemol is sometimes prescribed for the treatment of eczematous otitis externa, an inflammatory condition affecting the outer ear canal.

Formulations and Dosage

Synemol is available in various formulations, including:

• Creams: Synemol cream is available in concentrations of 0.01%, 0.025%, and 0.05%. It is usually applied as a thin film to the affected area two to four times daily, depending on the severity of the condition.
• Gels: Synemol gel is available in a concentration of 0.05%. It is applied to the affected area two to four times daily.
• Ointments: Synemol ointment is available in concentrations of 0.01%, 0.025%, and 0.05%. It is applied to the affected area two to three times daily.
• Eye implants: Fluocinolone acetonide intravitreal implants, such as Retisert and Iluvien, are used for the treatment of non-infectious uveitis and diabetic macular edema, respectively. These implants are surgically inserted into the eye and provide sustained release of the medication over an extended period.

The choice of formulation and concentration depends on the type and severity of the condition being treated, as well as patient preferences and tolerability.

Side Effects of Synemol

Like all medications, Synemol may cause side effects. Common side effects of Synemol include:

• Burning, stinging, or itching at the application site
• Dryness, redness, or irritation of the skin
• Skin discoloration or thinning
• Folliculitis (inflammation of hair follicles)
• Acne or worsening of existing acne

In rare cases, Synemol may cause more severe side effects, such as:

• Skin infections
• Allergic reactions (rash, hives, itching, difficulty breathing)
• Adrenal suppression (when used over large areas or for prolonged periods)
• Cushing’s syndrome (when used in high doses or for extended periods)

Long-term use of Synemol may also lead to skin atrophy, striae (stretch marks), and telangiectasia (dilated blood vessels). It is essential to follow the prescribed dosage and duration of treatment to minimize the risk of side effects. Patients should inform their healthcare provider if they experience any persistent or severe side effects while using Synemol.

Comparison to Other Topical Corticosteroids

Synemol belongs to the class of topical corticosteroids, which includes various other medications with similar mechanisms of action. Topical corticosteroids are classified into seven potency groups, with class I being the most potent and class VII being the least potent. Synemol is considered a mid-potency corticosteroid, falling into class III to V, depending on the formulation and concentration.

Several studies have compared the efficacy and safety of Synemol with other topical corticosteroids. A randomized, double-blind study comparing Synemol 0.025% cream with hydrocortisone 1% cream in patients with atopic dermatitis found that Synemol was significantly more effective in reducing symptoms and improving quality of life, with a similar safety profile.

Another study comparing Synemol 0.01% cream with betamethasone valerate 0.1% cream in patients with psoriasis showed that both treatments were effective in reducing psoriasis severity, with Synemol demonstrating a slightly better safety profile.

However, the choice of topical corticosteroid depends on various factors, including the type and severity of the condition, patient age, and treatment location. Healthcare professionals consider these factors when selecting the most appropriate medication for each patient.

Synemol Alternatives and Comparisons

In some cases, patients may require alternatives to Synemol, either due to ineffectiveness, side effects, or personal preferences. Some alternatives to Synemol include:

• Prescription topical corticosteroids: Other topical corticosteroids with similar potency, such as triamcinolone acetonide, betamethasone valerate, or fluticasone propionate, may be prescribed as alternatives to Synemol.
• Non-steroidal topical medications: Topical calcineurin inhibitors, such as tacrolimus and pimecrolimus, or phosphodiesterase-4 inhibitors, like crisaborole, may be used for the treatment of atopic dermatitis and other inflammatory skin conditions.
• Over-the-counter (OTC) products: For mild to moderate cases of dermatitis or eczema, OTC products containing hydrocortisone, colloidal oatmeal, or ceramides may be used to alleviate symptoms.
• Phototherapy: Ultraviolet (UV) light therapy, such as narrowband UVB or PUVA, may be recommended for the treatment of psoriasis or other skin conditions that do not respond adequately to topical medications.
• Systemic medications: In severe or widespread cases of skin conditions, systemic medications such as oral corticosteroids, methotrexate, cyclosporine, or biologics may be prescribed.

The choice of alternative treatment depends on the specific condition, its severity, and patient-related factors. Healthcare professionals work closely with patients to determine the most suitable alternative when Synemol is not the optimal choice.

Cost and Accessibility

The cost of Synemol varies depending on the formulation, concentration, and packaging size. In the United States, the average retail price of Synemol 0.025% cream (15 g) is approximately $50 to $60, while the 0.05% cream (15 g) may cost around $70 to $80. However, prices can vary significantly depending on the pharmacy, location, and insurance coverage.

Many insurance plans, including Medicare and Medicaid, cover Synemol when prescribed by a healthcare professional. Patients with insurance may be responsible for a copayment or coinsurance, depending on their specific plan. Some manufacturers also offer patient assistance programs for individuals who are uninsured or underinsured and meet certain eligibility criteria.

Generic versions of fluocinolone acetonide, the active ingredient in Synemol, are available and may be more affordable than the brand-name product. The cost-effectiveness of Synemol compared to other topical corticosteroids or alternative treatments depends on various factors, such as the duration of treatment, potency, and patient response.

Synemol is widely available in the United States and many other countries. It can be obtained through prescription from dermatologists, primary care physicians, and other healthcare providers. Some formulations, such as the 0.01% cream, may also be available over the counter in certain regions.

Regulatory and Safety Information

Synemol, containing the active ingredient fluocinolone acetonide, has been approved by the United States Food and Drug Administration (FDA) for the treatment of various skin conditions. The FDA has reviewed the safety and efficacy data from clinical trials and determined that the benefits of using Synemol outweigh the potential risks when used as directed.

However, like all medications, Synemol carries certain risks and side effects. To ensure safe use, patients should follow the instructions provided by their healthcare provider and the product label. Some key safety guidelines for using Synemol include:

• Apply a thin layer of the medication to the affected area as directed, typically two to four times daily.
• Avoid applying Synemol to the face, groin, or axillae unless specifically instructed by a healthcare professional.
• Do not use Synemol for longer than the prescribed duration, as prolonged use may increase the risk of side effects.
• Notify your healthcare provider if you experience any persistent or severe side effects, such as skin irritation, infection, or adrenal suppression symptoms.
• Do not use Synemol on open wounds or infected areas of the skin without consulting your healthcare provider.
• Avoid applying other topical products, such as moisturizers or cosmetics, to the same area unless advised by your healthcare provider.

Patients should also inform their healthcare provider about any preexisting medical conditions, allergies, or medications they are taking before starting treatment with Synemol. Pregnant or breastfeeding women should consult their healthcare provider before using Synemol, as the safety of the medication in these populations has not been fully established.

Pharmacokinetics and Pharmacodynamics

Pharmacokinetics and pharmacodynamics are essential aspects of understanding how Synemol works in the body. Pharmacokinetics describes how the body processes the medication, including absorption, distribution, metabolism, and excretion. Pharmacodynamics, on the other hand, refers to the effects of the medication on the body.

When applied topically, fluocinolone acetonide, the active ingredient